Skip to main content
. 2017 Dec 21;17:881. doi: 10.1186/s12885-017-3891-3

Fig. 5.

Fig. 5

The differential diagnostic performance of N-glycan biomarkers in IgD MM. a The abundance of NA2FB/NG1(3)A2F (peak 7/peak 4) was significantly increased in patients with IgD MM compared with those with LCMM. b The ROC curve demonstrated the ability of the serum NA2FB/NG1(3)A2F levels to differentially diagnose IgD MM from LCMM